• El.En. 1H 2026 revenue rose 9.1% to EUR 246.5 million; net income attributable to shareholders climbed 45.5% to EUR 26.1 million.
• EBIT jumped 37.6% to EUR 43.4 million; EBITDA increased 30% to EUR 48.7 million.
• Net cash improved to EUR 184.5 million at June 30 from EUR 172.2 million at Dec. 31, 2025.
• Medical revenue rose 10.4% to EUR 227.5 million, reaching 92.3% of group revenue; Italy fell 15.6%, Europe rose 8%.
• Guidance reaffirmed to lift revenue and operating profit versus 2025; CEO Gabriele Clementi cited growth driven entirely by medical operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. El.En. S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 0481-59-2026_TELEBORSA.pdf), on September 10, 2026, and is solely responsible for the information contained therein.